🇺🇸 FDA
Patent

US 10292986

Methods for treating epithelian mesenchymal transition related diseases

granted A61KA61K31/551A61K45/06

Quick answer

US patent 10292986 (Methods for treating epithelian mesenchymal transition related diseases) held by The Board of Regents of the University of Texas System expires Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/551, A61K45/06